Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03355560
Title Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sulsau-Ul Haque
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
UC Health Cincinnati Ohio 45219 United States Details
*Shaded cells indicate that there was no data available from for the field